The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


Dr. Shivani Pasricha is a laboratory head in the Department of Infectious Diseases at the Doherty Institute, spearheading rapid point-of-care diagnostics for infectious diseases with advanced technologies like CRISPR. She holds honorary positions at Victorian Infectious Diseases Reference Laboratory and the Walter and Eliza Hall Institute, and sits on the executive committee for the ARC funded ITRP antimicrobial resistance hub, world-first partnership between industry, researchers and end users to transform AMR and stewardship. Her team utilizes molecular and genomic approaches to enhance detection, prevention, and surveillance of infectious diseases, addressing critical clinical challenges.

  • Key Achievements
    • Shivani earned her PhD from the Genetics Department at the University of Melbourne, where she authored several pioneering articles on fungal pathogenesis. During her postdoctoral tenure focused on Legionnaires Disease, Shivani gained recognition for her innovative research on Legionella nuclear effectors and amoebal infection, earning prestigious awards including the UniMelb ECR Research Grant, Lorne Infection and Immunity Career Development Award, and the Hudson Institute Next Big Idea Pitch Award

      Currently, she is recognised as a rising leader in rapid diagnostics and STI research, publishing in multiple high impact journals. In 2024, Shivani received the Gilead Fellowship and Norman Beischer Innovation Grant.

    Publications
    Loading ORCID data…
    Research Groups
    • Williamson group

      The Williamson research group focuses on the development and evaluation of new diagnostic tests, and the translation of genomic technologies to infectious diseases. Their research has directly influenced the way microbiology is applied to clinical practice and public health, including responses to antimicrobial resistance, sexually-transmitted pathogens and COVID-19. 


      Lab Team

      Williamson group